Randox now ranks 23rd in the global clinical diagnostics market and offer instrumentation and tests for clinical chemistry, immunology and quality control materials
Randox is a private company founded in 1982 and now manufactures 5% of the world's clinical chemistry products.
Throughout its 25 year operation, Randox has excelled in the design, manufacture and marketing of a vast range of high quality products for laboratory medicine.
Numerous awards have been won by Randox including four times winner of the Queens Award for Export, Northern Ireland Exporter of the year and the Ernst and Young Entrepreneur Award.
Another very prestigious award from the Royal Academy of Engineering was presented for biochip array technology in 2003.
Randox Laboratories is the world's first manufacturer of an automated protein biochip array platform and this innovative technology has proven to be the most revolutionary multi-analyte testing platform in the world.
Randox has a very strong R+D ethos with 200 R+D staff and reinvesting 20% of annual revenue in an effort to continuously improve the field of diagnostics.
Products cover a range of disease areas including cancer, cardiovascular disease, diabetes, drugs of abuse and thyroid and fertility disorders.
Randox production facilities are FDA compliant and the company currently have more tests in development than any other diagnostic company in the world.
The last 25 years have provided many successes for Randox Laboratories.
The dedication of the company to the improvement of diagnostics and the high quality of service delivered to the Clinical Diagnostics industry should guarantee many more successes in the future.
